Purchase Order 75D30124P19483

Award Date 9/17/24
Potential Completion Date 9/16/25
Potential Value $88K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Alexandria, VA 22312, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
This is a $32,000.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bioinforx, Inc., a small disadvantaged business. The contract is for the bulk procurement of oligos, with a period of performance ending on September 30, 2020. Bioinforx, Inc. is a for-profit organization that specializes in developing scientific data management systems and laboratory information technologies, particularly for government health agencies like the CDC and the...
This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Abclonal Science, Inc. (doing business as Abclonal Technology), a foreign-owned, self-certified small disadvantaged business. The $246,880.00 firm-fixed-price purchase order is for gene synthesis antibodies, with a completion date of August 30, 2020. The contract does not have a set-aside designation. Based on the agency and description, this contract...
The Centers for Disease Control and Prevention (CDC) awarded a $34,100.00 firm-fixed-price purchase order to Formulatrix, LLC, a foreign-owned, for-profit organization based in Bedford, Massachusetts. The contract is for the procurement of one Tangential Flow Filtration (TFF) system, along with training and installation qualification/operational qualification services. The TFF system will be used to purify and concentrate proteins, viruses, and RNA to support vaccine development needs at the...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $71,550.00 Firm Fixed Price Purchase Order to VWR International LLC for the delivery of DNA Preparation Kits. This award was made under the CDC's Division of Viral Diseases (DVD), National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD) program (major program code: CDC\DDID\NCIRD\DBD\R - CDC\DDID\NCIRD\DBD\RDB (HCVGGB)). The contract has an ultimate completion date of July 2, 2024...
The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...
This contract, awarded by the Centers for Disease Control and Prevention (CDC) to Genewiz, LLC, is for the rapid synthesis of gene sequences for the development of COVID-19 vaccine candidate viruses. The $248,947.75 firm fixed price purchase order does not have a set-aside designation. Genewiz, a global contract research organization, has provided DNA and RNA sequencing, gene synthesis, cloning, and other genomic services to various federal agencies through IDIQ contracts and other vehicles....
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
Genscript USA Inc. was awarded a $90,340 purchase order by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, Genscript will provide bulk antibody production services in support of the CDC's CVV (Comparative Vaccine Vector) program. Performance will take place at Genscript's facility in Chamblee, Georgia over the course of one year, from September 2022 through September 2023. The contract has a firm fixed price and no set-aside...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $159,300.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit provider of biomedical research and genetic analysis tools and technologies. The contract, which does not have a set-aside designation, is for the delivery of specialized gene expression products and services, including "TAC CARDS", to support the CDC's disease research, healthcare programs, and...

The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract worth $87,600 to Federon Procurement Solutions, a minority-owned, self-certified small disadvantaged business in Alexandria, Virginia. The contract is for the bulk production of oligonucleotides and synthetic genes to support the development of Candidate Vaccine Viruses (CVVs) at the CDC Influenza Division. This requirement was originally posted as an $87,600 Request for Quotations (RFQ) that was not a small business set-aside. The key objective is to facilitate the development of influenza CVVs, which are used as the starting materials for seasonal and pandemic influenza vaccines. Federon Procurement Solutions has a strong track record of providing specialized laboratory equipment, electronics, and other mission-critical items to various federal agencies through its past contract awards.

Generated 9/18/24, 9:46 AM